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Self-renewal capacity and pluripotency, which are controlled by 22 
Oct3/4-centered transcriptional regulatory network, are major characteristics of 23 
embryonic stem (ES) cells.  Nuclear hormone receptor Dax1 is one of the crucial 24 
factors in the network.  Here, we identified an orphan nuclear receptor Esrrb as a 25 
Dax1-interacting protein.  Interaction of Dax1 and Esrrb was mediated through 26 
LXXLL motifs of Dax1, and the activation- and ligand binding-domains of Esrrb.    27 
Furthermore, Esrrb enhanced the promoter activity of the Dax1 gene via direct binding 28 
to an Esrrb-binding site 1 (ERRE1) of the promoter.  Expression of Dax1 was 29 
suppressed followed by Oct3/4 repression; however, overexpression of Esrrb 30 
maintained expression of Dax1 even in the absence of Oct3/4, indicating that Dax1 is a 31 
direct downstream target of Esrrb, and that Esrrb can regulate Dax1 expression in an 32 
Oct3/4-independent manner.  We also found that transcriptional activity of Esrrb was 33 
repressed by Dax1.  Furthermore, we revealed that Oct3/4, Dax1 and Esrrb have a 34 
competitive inhibition capacity for each complex.  These data together with previous 35 
findings suggest that Dax1 functions as a negative regulator of Esrrb and Oct3/4, and 36 
these molecules form a regulatory loop for controlling pluripotency and self-renewal 37 





Pluripotency and self-renewal capacity are major characteristics of murine 41 
embryonic stem (ES) cells.  Leukemia inhibitory factor (LIF) plays an important role 42 
for the self-renewal of ES cells; and depletion of LIF from ES cell-culture medium leads 43 
to spontaneous differentiation of cells and results in a failure of self-renewal (1, 2).  A 44 
large number of transcription factors function downstream of signaling by LIF, and 45 
several transcription factors including STAT3, Oct3/4, Sox2 and Nanog play crucial 46 
roles for pluripotency and self-renewal of ES cells (3-5).  Artificial activation of 47 
STAT3, which is achieved by 4-hydroxytamoxifen stimulation of nuclear localization of 48 
the STAT3-estrogen receptor fusion protein (STAT3ER), as well as forced expression of 49 
Nanog accelerate the self-renewal in a LIF-independent manner (6-8).  50 
Oct3/4-deficient embryos develop to the blastocyst stage, but their inner cell mass 51 
(ICM), from which ES cells are established, loses pluripotency; and the deletion of 52 
Oct3/4 expression in ES cells promotes differentiation into extraembryonic 53 
trophectodermal cells (9, 10).  Sox2-deficient blastocysts form abnormal ICM and fail 54 
to outgrowth (11).  ES cells lacking the Sox2 gene, differentiate into trophoblast cells 55 
(12). 56 
Actually, these transcription factors collaboratively regulate gene expression 57 
with other factors and contribute to maintenance of pluripotency and self-renewal of ES 58 
cells.  For instance, Oct3/4 interacts with Sox2, and this complex enhances expression 59 
of ES cell-specific genes including Fgf4, Lefty1, Nanog, UTF1, and Sox2 (13).  60 
β-catenin is also a binding partner of Oct3/4, and the complex regulates expression of 61 
the Nanog gene (14).  Nanog associates with NFκB family proteins including RelA, 62 
RelB and cRel.  Of note, NFκB increases during differentiation of ES cells; in contrast, 63 
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Nanog inhibits NFκB activation, and maintains pluripotency of ES cells (15).  Nanog 64 
also physically interacts with Smad1 and represses the differentiation-inducing activity 65 
of Smad1 (16).  Recently, high-throughput analyses revealed that a large number of 66 
proteins including transcription factors, chromatin remodelers, epigenetic factors, 67 
metabolism regulators, and cell cycle regulators associate with Oct3/4 or Nanog, and 68 
these factors form protein-interaction networks for controlling pluripotency and 69 
self-renewal of ES cells (17-19).  70 
Previously, we identified Dax1 (dosage-sensitive sex reversal, adrenal 71 
hypoplasia critical region, on chromosome X, gene 1; Nr0b1) as an Oct3/4-interacting 72 
protein (20). Dax1 belongs to a nuclear receptor superfamily.  It consists of a 73 
N-terminal DNA-binding domain and C-terminal ligand-binding domain. The 74 
DNA-binding domain includes three LXXLL-motifs, which play an important role for 75 
protein-protein interaction.  The C-terminal ligand-binding domain is similar to other 76 
nuclear receptors; however, a specific ligand of Dax1 has not been identified, and thus 77 
Dax1 is classified as an orphan nuclear receptor.  Dax1 is specifically expressed in 78 
self-renewing ES cells (21).  Expression of Dax1 is regulated by several transcription 79 
factors including STAT3, Oct3/4 and LRH-1 in ES cells (21, 22).  Dax1 associates 80 
with the POU-specific domain of Oct3/4 and as a result, transcriptional activity of 81 
Oct3/4 is repressed by Dax1.  Since hyper-activation of Oct3/4 leads to differentiation 82 
of ES cells (10), Dax1 functions as a negative regulator of Oct3/4 to maintain 83 
self-renewal of ES cells (20). 84 
To understand additional functions of Dax1 in ES cells, we performed a yeast 85 
two-hybrid screening and identified an orphan nuclear hormone receptor Esrrb (estrogen 86 
related receptor beta) as a Dax1-interacting protein, and the finding is in agreement with 87 
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previous investigations (18, 23).  Here, we discovered that Esrrb directly regulates the 88 
expression of Dax1, and Dax1 represses transcriptional activity of Esrrb.  Moreover, 89 
Oct3/4, Dax1 and Esrrb have a competitive inhibition capacity for their interaction.  90 
Our current study together with previous investigations suggests that Oct3/4, Dax1 and 91 
Esrrb form a regulatory loop and cooperatively regulate pluripotency and self-renewal 92 




MATERIALS AND METHODS 95 
Yeast two-hybrid screening.  Plasmids of pGBKT7-Dax1-full length (amino acids 1 - 96 
472), DNA-binding domain (DBD; amino acids 1 - 255), ligand-binding domain (LBD; 97 
amino acids 256 - 472) and Q23 region (amino acids 101 - 379) were constructed by 98 
inserting each cDNAs into the pGBKT7 vector (Clontech, Mountain View, CA).  Since 99 
full-length Dax1, LBD and Q23 had auto-reporter activity in yeast, we used the DBD 100 
region for the screening.  Plasmids of pGBKT7-Dax1-DBD and pGADT7-mouse ES 101 
cDNA library (20) were transformed into AH109 yeast strain according to the 102 
manufacture’s protocol (Clontech).  The transformed yeasts were plated on minimal 103 
synthetic dropout (SD) medium lacking tryptophan, leucine, histidine and adenine with 104 
2 μg/mL 5-brom-4-chloro-3-indoly--D-galactopyramosid (X--Gal) (Wako Pure 105 
Chemical Industries, Osaka, Japan).  Plasmid DNAs were isolated from the 106 
-galactosidase positive yeasts and the insert sequences were determined. 107 
 108 
Cell culture.  ES cell lines A3-1 and ZHBTc4 were cultured on gelatin-coated dishes 109 
with LIF-supplemented Dulbecco’s modified Eagle’s medium (DMEM) as described 110 
previously (6, 10, 24, 25). Esrrb-expressing ZHBTc4 ES cells were established by 111 
introduction of pCAGIP-Flag-Esrrb into ZHBTc4 ES cells and cultured in the presence 112 
of 1 μg/mL puromycin (Nacalai Tesque, Kyoto, Japan).  Human embryonic kidney 113 
(HEK) 293 cells were cultured in DMEM containing 10% fetal bovine serum. 114 
 115 
Plasmid construction.  Construction of mammalian expression vectors, 116 
pCMV5-Flag-MBP, pCAG-IP, pCAGIP-Myc, and pCAGIP-Flag was described before 117 
(20).  Plasmids including pCAGIP-Oct3/4, pCAGIP-Myc-Oct3/4, pCAGIP-Myc-Dax1, 118 
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pCAGIP-Flag-Dax1, pCMV5-Flag-MBP-Dax1 and their derivatives were described 119 
previously (20).  Truncated mutants of Dax1 were amplified by PCR using primers 120 
listed in Table S1 in the Supplemental Material and cloned into pCMV5-Flag-MBP.  121 
The coding regions of mouse Esrrb, as well as their mutants, were amplified by PCR 122 
using primers listed in Table S1.  pCAGIP-Esrrb, pCAGIP-Myc-Esrrb,  123 
pCAGIP-Flag-Esrrb, pCMV5-Flag-MBP-Esrrb and their derivatives were constructed 124 
by inserting corresponding coding sequences into expression vectors as described 125 
before (20).  Three LXXLL motifs-mutated Dax1, which we named Dax1 LTm, was 126 
constructed by PCR using primers listed in Table S1.  For mutations, the 1st LYNLL, 127 
the 2nd LYSML, and the 3rd LYSLL amino acids sequences were changed into 128 
LYNAA, LYSAA, and LYSAA, respectively.  The coding region of Dax1 LTm was 129 
cloned into either pCAGIP-Myc or pCMV5-Flag-MBP.   130 
The reporter plasmid, pGL4.10-Dax1 promoter 2.1 kb (pDax1-luc 131 
(-2042/+26) was described previously (21).  The promoter region of the Dax1 gene 132 
(-546 bp region) was amplified by PCR and cloned into either pGL2 basic or pGL4.10 133 
(Promega, Madison, WI), and these plasmids were termed pGL2-Dax1P 546 bp and 134 
pGL4.10-Dax1P 546 bp, respectively.  To construct ERRE mutated pGL4.10-Dax1P 135 
546 bp plasmids, mutated ERRE1 and/or ERRE2 elements were constructed by PCR 136 
using specific primers.  PCR products were cloned into pGL4.10 and termed either 137 
pGL4.10-Dax1P 546 bp-mutERRE1, -mutERRE2, or -mutERRE1&2.  To construct 138 
reporter plasmids of Oct3/4-responsive elements of the Esrrb gene, approximately 500 139 
bp sequences including either the 1st Oct3/4-binding site (+8924 to +8931) or the 2nd 140 
Oct3/4-binding site (+34733 to +34740) were amplified by PCR and cloned into 141 
pGL4-promoter (26), and we termed these plasmids as pGL4P-Oct3/4#A and 142 
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pGL4P-Oct3/4#B.  To construct Oct3/4-binding site mutated pGL4P-Oct3/4#A 143 
plasmid, the mutated Oct3/4-binding element was constructed by PCR using specific 144 
primers.  PCR product was cloned into pGL4-promoter and termed pGL4P-Oct3/4#A 145 
mutant.   To construct reporter plasmids of Esrrb-responsive elements of the Esrrb 146 
gene, approximately 500 bp sequences including either the 1st Esrrb-binding site 147 
(Esrrb-ERRE1, +9711 to +9719), the 2nd site (Esrrb-ERRE2, +31943 to +31951), the 148 
3rd site (Esrrb-ERRE3, +33435 to +33443 ), or the 4th site (Esrrb-ERRE4, +34403 to 149 
+34411) were amplified by PCR and cloned into pGL4-promoter; and we termed these 150 
plasmids as pGL4P-Esrrb-ERRE1, -ERRE2, -ERRE3 and -ERRE4, respectively.  To 151 
construct Esrrb-binding site mutated pGL4P-Esrrb-ERRE2 and -ERRE4 plasmids, 152 
mutated Esrrb-binding elements were constructed by PCR using specific primers.  153 
PCR products were cloned into pGL4-promoter and termed pGL4P-Esrrb-ERRE2 154 
mutant and -ERRE4 mutant, respectively. 155 
Esrrb siRNA expression vector, pFIV-H1/U6-Esrrb#3-Puro was constructed 156 
by inserting annealed oligonucleotides against Esrrb into pFIV-H1/U6-Puro (System 157 
Biosciences, Mountain View, CA).  All primer and oligonucleotide sequences used in 158 
the study are listed in Table S1. 159 
 160 
Plasmid transfection and luciferase assay.  Plasmids were introduced into cultured 161 
cells by using lipofectamine 2000 (Invitrogen, Carlsbad, CA).  One day after 162 
transfection, the medium was replaced with fresh medium.  For transient-transfection 163 
experiments, samples were analyzed 48h after transfection.  To establish stable 164 
transfectants, ES cells were reseeded 48h after transfection and treated with puromycin 165 
for another 3-5 days. 166 
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        For luciferase assay, cell extracts were prepared 48h after transfection, and 167 
luciferase activities in the extracts were measured by using a luciferase assay kit 168 
(Promega) with an AB-2200 (ATTO, Tokyo, Japan). 169 
 170 
Reverse transcription-PCR (RT-PCR) and quantitative RT-PCR (qRT-PCR).  171 
Total RNAs were isolated from ES cells with sepasol reagent (Nakalai Tesque) and 172 
converted to cDNAs by ReverTraAce (Toyobo, Osaka, Japan) with oligo(dT)12-18 173 
primers (NIPPON EGT, Toyama, Japan).  Gene expression was determined by PCR 174 
using specific primers.  For quantification, qRT-PCR using Sybr Green (MxPro 175 
Mx3005P, Stratagene, La Jolla, CA) was performed, and expression levels of target 176 
genes were normalized with GAPDH.  Primer sequences are listed in Table S1.  No 177 
PCR products were amplified in non-RT samples (Fig. S1). 178 
 179 
Western blot analysis and maltose binding protein (MBP) pull-down assay.  ES 180 
cells lysates were subjected to Western blot analysis using anti-Oct3/4 (sc-9081; Santa 181 
Cruz Biotechnology), anti-Dax1 (39984, Active Motif, CA), anti-Esrrb (PP-H6705-00, 182 
Perseus Proteomics, Tokyo, Japan) or anti-α-Tubulin (MP Biomedicals, Solon, OH) 183 
antibodies, followed by horseradish peroxidase conjugated anti-mouse or anti-rabbit 184 
antibodies (Millipore, Billerica, MA).  The blot was visualized by using enhanced 185 
chemiluminescence reagents (PerkinElmer, Waltham, MA) with LAS-1000 image 186 
analyzer (Fuji Film, Tokyo, Japan).   187 
MBP pull-down assay was performed as described previously (20).  Briefly, 188 
cell lysates were incubated overnight at 4°C with amylose resin.  The beads were 189 
washed three times with a washing buffer (50 mM Tris-HCl [pH 7.5], 2 mM MgCl2 and 190 
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150 mM NaCl), and the bound proteins were eluted by boiling in 2 x sodium dodecyl 191 
sulfate (SDS) sample buffer and subjected to Western blot analysis using anti-Myc 192 
(sc-40; Santa Cruz Biotechnology, Santa Cruz, CA), anti-Flag (F3165; Sigma-Aldrich, 193 
St. Louis, MO), anti-Oct3/4, or anti-Esrrb antibodies. 194 
 195 
Preparation of nuclear extracts and biotin-labeled DNA pull-down assay.  Nuclear 196 
extracts were isolated from A3-1 ES cells.  Cells were resuspended in a buffer 197 
consisting of 20 mM HEPES (pH 7.9), 20% glycerol, 10 mM NaCl, 0.2 mM EDTA (pH 198 
8.0) and 1.5 mM MgCl2 with protease inhibitors (1 mM DTT, 10 μg/mL leupeptin, 10 199 
μg/mL pepstatin and 10 μg/mL aprotinin).  After incubation on ice for 15 min, samples 200 
were spun down at 1,000 rpm for 10 min to pellet the nuclei.  The pellet was 201 
resuspended at 2.5×10
7 
nuclei/mL in the same buffer, and then 62.5 μL of 5M NaCl was 202 
added to the 1 mL of sample.  After incubation at 4°C for 30 min, the sample was 203 
centrifuged at 10,000 rpm.  The supernatant was used as a nuclear extract. 204 
        For biotin-labeled DNA pull-down assay, 20 pmol of 3’-biotinylated 205 
oligonucleotide was annealed with a complementary oligonucleotide and incubated 206 
overnight at 4°C with 60 μg of nuclear extracts in the presence of streptavidin-agarose 207 
(Novagen, Darmstadt, Germany).  For competition assays, 50-fold non-labeled either 208 
wild-type or mutant oligonucleotide was added.  The beads were washed three times 209 
with the washing buffer, and signals were detected by Western blot analysis as 210 
described above. 211 
 212 
Knockdown of target genes.  Double-stranded siRNAs were purchased from Operon 213 
Biotechnologies (Huntsville, AL).  Their sequences were 5’-GCA GUC UGG UUG 214 
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UCG UAU AGG-3’ for Esrrb#1, 5’-UGA CUA AGA UCG UCU CGA AUC-3’ for 215 
Esrrb#2, 5’-ACC UGC ACU UCG AGA UGA UGG AGA UCC-3’ for Dax1 and 216 
5’-GCC ACA ACG UCU AUA UCA UGG-3’ for EGFP.  ES cells (1.5 × 105 cells) in 217 
a 6-cm dish were transfected with either siRNA or the siRNA expression vector using 218 
lipofectamine 2000. 219 
 220 
Chromatin immunoprecipitation assay.  Chromatin immunoprecipitation (ChIP) 221 
assay was performed according to manufacturer's protocol (Diagenode OneDay ChIP 222 
Kit, Nippon Gene, Tokyo, Japan).  Briefly, ES cells were fixed with formaldehyde and 223 
genomic DNA was sheared.  Normal murine IgG (sc-2025, Santa Cruz) and anti-Esrrb 224 
antibody were added to the sheared chromatin.  For the detection of precipitated 225 
genomic DNA, PCR analysis was performed using specific primers, and PCR products 226 






Screening of Dax1-interacting proteins.  To search for Dax1-interacting proteins, we 231 
performed a yeast two-hybrid screening using cDNA library of self-renewing A3-1 ES  232 
cells and identified several transcription factors including Rxrb (retinoid X receptor 233 
beta), LRH-1 (liver receptor homolog 1), Nanog and Esrrb (estrogen-related receptor 234 
beta).  Among them, we obtained Esrrb at the highest frequency; therefore, we further 235 
analyzed the relationship between Dax1 and Esrrb. 236 
 237 
Esrrb and Dax1 are expressed specifically in self-renewing ES cells.  First, we 238 
examined whether expression of Esrrb correlates with Dax1 expression in A3-1 ES cells.  239 
RT-PCR and Western blot analyses revealed that expression of Esrrb, as well as Dax1, 240 
was detected in undifferentiated ES cells, and their expression was reduced upon 241 
differentiation induced by LIF depletion (Fig. 1A and 1C). 242 
We also examined Esrrb expression in ZHBTc4 ES cells (Oct3/4 conditional 243 
knockout ES cells) (10).  Tet stimulation completely repressed the expression of 244 
Oct3/4, which was recovered by removal of Tet.  Esrrb and Dax1 expression 245 
dramatically decreased by Tet stimulation and was restored after Tet removal as 246 
described previously (21, 27) (Fig. 1B and 1D), indicating that expression of Esrrb and 247 
Dax1 correlated with levels of Oct3/4 in ES cells. 248 
Since Dax1 is characterized as a direct downstream target of Oct3/4 (21), we 249 
examined the possibility that Esrrb is also a downstream target of Oct3/4.  The Esrrb 250 
gene contains two putative Oct3/4-binding sites, which we named Oct3/4 #A (+8924 - 251 
+8931) and Oct3/4 #B (+34733 - +34740) (Fig. S2A).  Luciferase assay demonstrated 252 
that the Oct3/4 #A region, but not the #B region, has enhancer activity in ZHBTc4 ES 253 
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cells, and the enhanced activity was reduced after treatment with Tet (Fig. S2B).  254 
When the Oct3/4 #A region was mutated, this element had no enhancer activity either in 255 
the presence or absence of Tet (Fig. S2C).  Taken together, these results suggest that 256 
one of the regulators of Esrrb is Oct3/4 in ES cells.  257 
 258 
Identification of Esrrb as a Dax1-interacting protein.  Esrrb and Dax1 are known to 259 
be component molecules of the Oct3/4-centered transcription factor network in ES cells 260 
(18).  Next, we confirmed the interaction between Dax1 and Esrrb and determined the 261 
interaction regions by using MBP pull-down assay in mammalian HEK293 cells.  To 262 
determine the Esrrb-binding region of Dax1, we prepared several truncated mutants of 263 
Dax1 including full-length of Dax1 (amino acids 1 - 472), DNA-binding domain (DBD, 264 
amino acids 1 - 255), Q1a (amino acids 1 - 100), Q1b (amino acids 68 - 139), Q23e 265 
(amino acids 136 - 202), and ligand-binding domain (LBD, amino acids 256 - 472) (Fig. 266 
2A).  Esrrb was precipitated strongly with full-length Dax1, DBD, Q1a (the 1st and the 267 
2nd LXXLL regions) and Q23e (the 3rd LXXLL region), and weakly with Q1b (the 2nd 268 
LXXLL region) and LBD (Fig. 2B), suggesting that the 3rd LXXLL region of Dax1 269 
strongly associates with Esrrb. 270 
To determine the Dax1-binding region of Esrrb, we prepared several truncated 271 
mutants of Esrrb including full-length Esrrb (amino acids 1 - 433), E1 (amino acids 1 - 272 
211), E2 (activation domain [AD], amino acids 1 - 168), E3 (amino acids 169 - 433), E4 273 
(ligand-binding domain [LBD], amino acids 212 - 433), E5 (amino acids 93 - 433) and 274 
E7 (DNA-binding domain [DBD], amino acids 93 - 211) (Fig. 3A).  Dax1 was 275 
precipitated strongly with full-length Esrrb, E3 and E4 regions, and weakly with E2 and 276 
E5 regions, but not with E1 and E7 regions (Fig. 3B), suggesting that Dax1 binds to the 277 
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AD and LBD regions of Esrrb, but a part of the DBD region of Esrrb may act as an 278 
inhibition domain for the association of Dax1 and Esrrb. 279 
 280 
LXXLL motifs of Dax1 are crucial for the interaction with Esrrb but not with 281 
Oct3/4.  The results described above show that Esrrb binds to the LXXLL region of 282 
Dax1.  Importantly, Oct3/4 also binds near the LXXLL region of Dax1 (20) (Fig. S3A 283 
and S3B).  Next, we constructed LXXLL motifs-mutated Dax1 (Dax1 LTm) (Fig. 284 
S4A).  As shown in Fig. S4B and S4C, Dax1 LTm was not able to interact with Esrrb; 285 
whereas, the mutant associated with Oct3/4.  These results revealed that LXXLL 286 
motifs of Dax1 are crucial for the interaction with Esrrb but not with Oct3/4. 287 
 288 
Esrrb regulates Dax1 expression in ES cells.  Esrrb is a transcriptional regulator, and 289 
its recognition DNA sequence is known to be TCAAGGTCA (28).  Interestingly, we 290 
discovered that the promoter region of the Dax1 gene contains two putative Esrrb 291 
binding sites, which we named Dax1-ERRE1 (-129 to -121) and Dax1-ERRE2 (-334 to 292 
-326) (Fig. 4A).  This finding indicates that Dax1 is not only a protein-protein 293 
interaction partner of Esrrb, but a downstream target of Esrrb.  To explore this 294 
possibility, we first performed luciferase reporter assay.  When we examined -2.1 kb of 295 
the promoter region of the Dax1 gene, the promoter activity increased by 296 
overexpression of Esrrb in A3-1 ES cells (Fig. 4B).  We also examined the activity of 297 
-0.5 kb of the promoter region of the gene in A3-1 ES cells and found that the enhanced 298 
promoter activity of the region decreased by knocking-down of Esrrb (Fig. 4C).  These 299 
results suggest that Esrrb positively regulates the promoter activity of the Dax1 gene. 300 
To determine which ERRE sites are involved in regulation of Dax1 expression, 301 
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we examined four reporter plasmids including wild-type (WT), ERRE1 mutated 302 
(mutERRE1), ERRE2 mutated (mutERRE2), and ERRE1 and 2 mutated (mut 303 
ERRE1&2) promoters (Fig. 5A).  As shown in Fig. 5B, enhanced promoter activity 304 
was reduced when ERRE1, but not ERRE2, was mutated, suggesting that ERRE1 is 305 
required for the activation of the Dax1 promoter. 306 
Next, we performed biotinylated DNA pull-down assay to examine for an 307 
interaction of Esrrb with the Dax1-ERRE1 element.  Nuclear extracts of 308 
undifferentiated ES cells were incubated with a biotin-labeled oligonucleotide carrying 309 
Dax1-ERRE1 and precipitated by streptavidin-agarose.  Endogenous Esrrb was 310 
precipitated by biotinylated Dax1-ERRE1 oligonucleotides, and the precipitate 311 
disappeared in the presence of 50-fold non-labeled wild-type ERRE1 oligonucleotides, 312 
suggesting that endogenous Esrrb binds to the Dax1-ERRE1 element in vitro (Fig. 5C). 313 
To examine further whether endogenous Esrrb binds to the element in vivo, 314 
we performed chromatin immunoprecipitation assays.  As shown in Fig. 5D, ERRE1 315 
of the Dax1 gene was precipitated by anti-Esrrb antibody in A3-1 ES cells.  Taken 316 
together, these results suggest that Dax1 is a direct downstream target of Esrrb in ES 317 
cells. 318 
 319 
Esrrb regulates expression of Dax1 in an Oct3/4-independent manner.  Current 320 
finding together with our previous observation (20) revealed that Dax1 is a downstream 321 
target of both Oct3/4 and Esrrb.  Here, we examined whether Esrrb is able to regulate 322 
Dax1 expression in the absence of Oct3/4.  For this, we established 323 
Esrrb-overexpressing ZHBTc4 ES cells.  Expression of Dax1, as well as Oct3/4, in the 324 
control ZHBTc4 ES cells was repressed in the presence of Tet; however, expression of 325 
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Dax1 was maintained in Esrrb-overexpressing ZHBTc4 ES cells even in the absence of 326 
Oct3/4 (Fig. 6A). 327 
Next, we verified the effect of Esrrb knockdown upon Dax1 expression.  As 328 
shown in Fig. 6B, two independent Esrrb RNAi decreased expression levels of 329 
endogenous Dax1 mRNA.  Also, expression level of Dax1 protein was reduced by 330 
Esrrb knockdown (Fig. 6C).  Interestingly, endogenous Oct3/4 was maintained in the 331 
Esrrb knockdown condition, suggesting that Esrrb is able to regulate Dax1 expression in 332 
an Oct3/4-independent manner. 333 
 334 
Esrrb regulates expression of Esrrb in ES cells.  We also found an auto-regulation 335 
pathway of Esrrb gene expression.  The Esrrb gene contains four putative 336 
Esrrb-responsive elements (Esrrb-ERRE1 to 4) in its intron regions (Fig. S5A); and 337 
Esrrb-ERRE2 and Esrrb-ERRE4 had enhanced reporter activities in A3-1 ES cells (Fig. 338 
S5B).  Of note, enhancer activities of the Esrrb-ERRE2 and Esrrb-ERRE4 were 339 
reduced by either knocking-down endogenous Esrrb expression (Fig. S5C and S5D) or 340 
introducing mutations into the elements (Fig. S5E and S5F).  Biotinylated DNA 341 
pull-down assay revealed that endogenous Esrrb associates with Esrrb-ERRE2 and 342 
Esrrb-ERRE4 (Fig. S5G).  Taken together, these findings indicate that Esrrb is able to 343 
regulate its expression via Esrrb-ERRE2 and Esrrb-ERRE4 in ES cells.   344 
 345 
Dax1 inhibits transcriptional activity of Esrrb. To understand the significance of the 346 
interaction between Dax1 and Esrrb, we examined the effects of Dax1 on the 347 
transcriptional activity of Esrrb using reporter plasmids carrying either the promoter 348 
region of the Dax1 gene or Esrrb-responsive elements (ERRE2 and ERRE4) of the 349 
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Esrrb gene. 350 
The promoter activity of the Dax1 gene was enhanced by Esrrb, and the 351 
enhanced activity was repressed by Dax1 in HEK293 cells (Fig. 7A).  Similarly, 352 
promoter activity was stimulated by Esrrb, and the activity was suppressed by Dax1 in 353 
A3-1 ES cells (Fig. 7B).  Unlike the case of HEK293 cells, Dax1 promoter activity 354 
was suppressed by Dax1 itself in A3-1 ES cells, indicating that Dax1 represses 355 
endogenous Esrrb transcriptional activity.  Also, enhancer activities of ERRE2 and 356 
ERRE4 regions of the Esrrb gene, where Esrrb directly binds, were repressed by 357 
overexpression of Dax1 in ES cells (Fig. 7C and 7D).  These data suggest that Dax1 358 
functions as a negative regulator of Esrrb.    359 
 360 
Oct3/4, Dax1 and Esrrb have a competitive inhibition capacity for their 361 
interaction. 362 
Next, we examined the relationship between Esrrb, Dax1 and Oct3/4.  We 363 
performed competitive MBP pull-down assay.  As shown in Fig. 8A, Oct3/4 was 364 
co-precipitated with MBP-Dax1 in the absence of Esrrb, whereas the amount of 365 
precipitated Oct3/4 was reduced in the presence of Esrrb in a dose-dependent manner.  366 
Similarly, Esrrb was co-precipitated with MBP-Dax1 in the absence of Oct3/4, and the 367 
amount of precipitated Esrrb was reduced in the presence of Oct3/4 in a dose-dependent 368 
manner (Fig. 8B), suggesting that Esrrb or Oct3/4 exclusively binds by Dax1. 369 
Since Dax1 LTm binds to Oct3/4 but not Esrrb, we demonstrated competitive 370 
MBP pull-down assay by using the mutant Dax1.  As shown in Fig. 8C, Oct3/4 was 371 
co-precipitated with MBP-Dax1 LTm in the absence of Esrrb; whereas, the amount of 372 
precipitated Oct3/4 was reduced in the presence of Esrrb in a dose-dependent manner, 373 
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although Esrrb was not co-precipitated with MBP-Dax1 LTm.  This finding is probably 374 
explained as follows: Oct3/4 and Esrrb are known to form complex in ES cells (18, 29). 375 
Although Oct3/4 associates with Dax1 LTm in the absence of Esrrb, Oct3/4 changes a 376 
binding-partner to Esrrb in a dose-dependent manner.  Taken together, these results 377 
suggest that three complexes including Oct3/4-Dax1, Oct3/4-Esrrb, and Dax1-Esrrb 378 
exist in cells; and Oct3/4, Dax1 and Esrrb have a competitive inhibition capacity for 379 
each complex. 380 
 381 
Inhibition of Dax1-Esrrb interaction causes up-regulation of endodermal marker 382 
genes.  To investigate functions of Esrrb-Dax1 complex in ES cells, Dax1 RNAi was 383 
introduced into Esrrb-overexpressing ES A3-1 cells.  Since the transfected cells have 384 
both overexpressed Esrrb and repressed Dax1, expression level of the two genes is 385 
unbalanced; and therefore Esrrb-Dax1 complex would be disrupted in the cells.  When 386 
we examined gene expressions of the cells, expression level of endodermal marker 387 
genes (Gata4, Gata6 and Dab2), but not mesodermal (T) and ectodermal (Fgf5) genes, 388 
were significantly enhanced in Dax1 RNAi-transfected Esrrb-overexpressing ES cells 389 
(Fig. 9A).  Enhanced expression of the endodermal marker genes also observed in 390 
Esrrb- and Dax1 LTm-co-overexpressed ES cells, where Esrrb-Dax1 complex would be 391 
disrupted (Fig. 9B).  Previous investigations showed that Esrrb-overexpressing ES 392 
cells are prone to differentiate into endoderm (5, 30).  Taken together, these results 393 
suggest that Esrrb enhances the expression of endodermal genes to induce 394 
differentiation into endoderm, and Dax1 represses endodermal genes expression via 395 




Esrrb (estrogen-related receptor beta) is a member of the nuclear hormone 398 
receptor superfamily and belongs to the subfamily 3 (estrogen receptor type).  In mice, 399 
Esrrb-deficient embryos are embryonic lethal at E10.5 because of placental hypoplasia, 400 
suggesting that Esrrb is involved in placental formation (31).  Complementation 401 
analysis of placental defects of the Esrrb-deficient embryo with wild-type tetraploid 402 
embryos revealed that Esrrb-deficient mice mature to adults, but the number of germ 403 
cells is significantly reduced in male and female gonads, showing that Esrrb is involved 404 
in proliferation of gonadal germ cells (32).  In addition, the mice exhibit circling 405 
behavior and head-tossing (32).  Conditional knockout mice of the Esrrb gene also 406 
exhibit head-bobbing and run in circle, which is caused by inner-ear defects (33).  Of 407 
note, several germline mutations of the Esrrb gene in individuals cause an 408 
autosomal-recessive, nonsyndromic hearing impairment, indicating that Esrrb is 409 
essential for inner-ear development (29, 34).  Taken together, these findings indicate 410 
that Esrrb has an important role during early embryogenesis, as well as organogenesis.  411 
In the present study, we revealed that Esrrb together with Oct3/4 and Dax1 regulates 412 
self-renewal of ES cells. 413 
Esrrb interacts with Oct3/4, and the association of Esrrb and Oct3/4 enhances 414 
the promoter activity of the Nanog gene (29).  Oct3/4 is able to bind to Dax1 as 415 
described in our previous study (20), as well as our current study.  Here, we found 416 
Esrrb interacts with Dax1, and the 1st and 3rd LXXLL motifs of Dax1 are crucial for 417 
the interaction.  Especially, Esrrb associates with the 3rd LXXLL motif of Dax1 rather 418 
than the 1st LXXLL motif.  We assume that Esrrb, Oct3/4 and Dax1 do not form a 419 
trimer complex.  Instead, Esrrb or Oct3/4 exclusively binds by Dax1.  Dax1 is known 420 
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to function as a transcriptional repressor (23, 35, 36).  Transcriptional activities of 421 
Oct3/4 and Esrrb are inhibited by Dax1.  As described previously, hyper-activation of 422 
Oct3/4 in ES cells leads to differentiation into primitive endoderm and mesoderm (10), 423 
and Dax1 inhibits the over-activation and contributes to retaining self-renewal (20).  A 424 
similar relationship would be anticipated between Dax1 and Esrrb.  Expression levels 425 
of Esrrb in ES colonies are heterogeneous (mosaic-in-colony pattern) (29, 37, 38).  Of 426 
note, Esrrb-overexpressing ES cells are known to be prone to differentiate into 427 
endoderm (5, 30).  We generated Esrrb-overexpressing ES cells, and Dax1 RNAi was 428 
introduced into the cells, where Esrrb-Dax1 complex would be disrupted.  Expression 429 
levels of self-renewal marker genes are comparable to control cells; whereas, that of 430 
endodermal marker genes were enhanced.  Enhanced expression of endodermal 431 
markers were also observed in Esrrb- and Dax1 LTm-co-overexpressed ES cells, where 432 
Esrrb-Dax1 complex would be disrupted, suggesting that Esrrb-Dax1 complex represses 433 
Gata6 to prevent differentiation of ES cells.  Concerning the Dax1-Oct3/4 complex, 434 
Dax1 represses the transcriptional activity of Oct3/4 by inhibiting the DNA binding 435 
activity of Oct3/4, since Dax1 associates with the DNA binding domain of Oct3/4 (20).  436 
In case of Dax1-Esrrb complex, the association is not mediated through the 437 
DNA-binding domain of Esrrb, suggesting that Dax1 will not inhibit the DNA binding 438 
capacity of Esrrb. 439 
Dax1 is a downstream target gene of STAT3 and Oct3/4 in ES cells (21).  440 
LRH-1 and SF-1 also regulate Dax1 gene expression in ES cells and adrenocortical 441 
carcinoma cells, respectively (22, 39); and the SF-1-mediated activation is repressed by 442 
Dax1 via binding to a hairpin structure in the promoter region (40).  Here, we found 443 
Dax1 is a downstream target gene of Esrrb.  Esrrb recognized the ERRE1 of the Dax1 444 
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gene and enhanced the promoter activity, and the Esrrb-mediated activation of the Dax1 445 
gene promoter was suppressed by Dax1 itself.  In MCF7 breast cancer cells, 446 
expression of Dax1 is regulated by Esrrg, but not Esrrb, via ERRE1 (41).   Esrrb and 447 
Esrrg belong to the same family, and its amino acid homology is about 70%.  Esrrg is 448 
not expressed in ES cells (data not shown).  Interestingly, Esrrg-mediated activation of 449 
the Dax1 promoter is repressed by Dax1 in MCF7 cells.  These findings indicate that 450 
an autoregulatory loop that controls Dax1 gene expression by the estrogen 451 
receptor-related receptors is conserved among several cell types.   452 
Here, we propose a novel regulatory loop among Dax1, Esrrb and Oct3/4 for 453 
controlling pluripotency and self-renewal of murine ES cells (Fig. 10).  Expression of 454 
Dax1 is induced by Oct3/4 and Esrrb (21).  Oct3/4 and Esrrb associate with each other 455 
(18, 29), and their expressions are either self-regulated and/or regulated by each other 456 
(42).  Also, three complexes including Oct3/4-Dax1, Oct3/4-Esrrb, and Dax1-Esrrb 457 
would exist in cells; and Oct3/4, Dax1 and Esrrb have a competitive inhibition capacity 458 
for each complex.  Transcriptional activities of Oct3/4 and Esrrb are repressed by the 459 
direct association with Dax1 (20).  As described above, hyper-activation of Oct3/4 460 
disrupts self-renewal of ES cells (10) and overexpression of Esrrb impairs pluripotency 461 
of ES cells (30), showing that appropriate levels of expression and/or activation of 462 
Oct3/4 and Esrrb are important for ES cells.  Dax1 functions as a negative regulator of 463 
Oct3/4 and Esrrb, and it plays essential roles for maintaining pluripotency and 464 
self-renewal capacity of ES cells.  In fact, knockdown of Dax1 induces expression of 465 
differentiation markers (43), and Dax1 conditional knockout in ES cells leads to 466 
differentiation (44).  Also, overexpression of Dax1 leads to downregulation of Sox2, 467 
Nanog, and Dax1 which are downstream target of Oct3/4 and Esrrb (20).  Recent 468 
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studies have shown that Oct3/4 and Dax1, as well as Esrrb, are part of the core 469 
protein-network in ES cells (17, 18).  During the revision of the manuscript, extensive 470 
studies of Esrrb were published.  Esrrb is a direct downstream target of Nanog and able 471 
to substitute for functions of Nanog in ES cells (45).  Also, Esrrb is a target gene of 472 
Gsk3/Tcf3 signal; and Esrrb is necessary and sufficient to control self-renewal of ES 473 
cells downstream of Gsk3 inhibition (46). Our current study extends these findings and 474 
clarifies biological significance of these interactions.  Further investigation of the 475 
complex protein-network in ES cells will further our understanding of the molecular 476 
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FIG. 1.   Dax1 and Esrrb are expressed specifically in self-renewing ES cells. (A) Reduction of Esrrb mRNA 
expression by LIF withdrawal. After culture with (+) or without (-) LIF for 3 - 6 days, expression of Esrrb, as well 
as Oct3/4 and Dax1, in A3-1 ES cells was examined by RT-PCR analysis.  (B) Reduction of Esrrb mRNA 
expression after repression of Oct3/4 expression.  ZHBTc4 ES cells were cultured in the presence of LIF with (+) 
or without (-) tetracycline (Tet [1μg/ml]) for 24h - 48h.  Expression of the indicated genes was examined by RT-
PCR.  To restore the expression of Oct3/4, the culture medium of Tet-treated cells was charged to a Tet-free 
medium, and the cells were cultured for another 24h.  GAPDH was used as an internal control.  (C) Reduction of 
Esrrb protein expression by LIF withdrawal.  A3-1 ES cells were cultured as described in (A), and expression of 
Esrrb and Dax1 was examined by Western blot analysis.  (D) Reduction of Esrrb protein expression after repression 
of Oct3/4 expression.  ZHBTc4 ES cells were cultured as described in (B), and expression of Esrrb and Oct3/4 was 
examined by Western blot analysis.  α-Tubulin was used as a loading control.  All results are representative of three 
separate experiments. 
Uranishi et al.  Fig.2 
FIG. 2.  Esrrb binds to LXXLL motifs of Dax1.  (A) Schematic view of Flag-MBP-Dax1 and its truncated mutants.  
Several Flag-tagged MBP-fused constructs including full-length of Dax1 (amino acids 1 - 472), DNA-binding 
domain (DBD, amino acids 1 - 255), Q1a (amino acids 1 - 100), Q1b (amino acids 68 - 139), Q23e (amino acids 
136 - 202) and ligand-binding domain (LBD, amino acids 256 - 472) were designed.  (B) Determination of Esrrb-
interaction domains of Dax1.  HEK293 cells were transfected with Myc-Esrrb together with Flag-MBP-Dax1 or its 
mutants.  MBP-fused proteins were pulled down by amylose resin, and precipitates were analyzed by Western 
blotting with anti-Myc antibody.  Expression of each protein was confirmed by Western blotting with anti-Myc and 
anti-Flag antibodies.  All results are representative of three separate experiments. 
Uranishi et al. Fig.3 
FIG. 3.  Dax1 binds to the activation domain (AD), as well as the ligand-binding domain (LBD) of Esrrb.  (A) 
Schematic view of Flag-MBP-Esrrb and its truncated mutants.  Several Flag-tagged MBP-fused constructs 
including full-length of Esrrb (amino acids 1 - 433), E1 (amino acids 1 - 211), E2 (amino acids 1 - 168), E3 (amino 
acids 169 - 433), E4 (amino acids 212 - 433), E5 (amino acids 93 - 433) and E7 (amino acids 93 - 211) were 
designed as described in Materials and Methods.  (B) Determination of Dax1-interaction domains of Esrrb.  
HEK293 cells were transfected with Myc-Dax1 together with Flag-MBP-Esrrb or its mutants. MBP-fused proteins 
were pulled down by amylose resin, and precipitates were analyzed by Western blotting with anti-Myc antibody.  
Expression of each protein was confirmed by Western blotting with anti-Myc and anti-Flag antibodies.  All results 







































































A3-1 ES cells A3-1 ES cells 
FIG. 4.  Esrrb positively regulates the promoter activity of the Dax1 gene.  (A) Esrrb-binding sites of the Dax1 gene.  
The promoter region of the Dax1 gene contains two Esrrb-binding sites called ERRE1 (-129 to -121) and ERRE2 (-
334 to -326).  (B) Transcriptional activity of Esrrb to the promoter region of the Dax1 gene.  A3-1 ES cells were 
transfected with pGL4.10-Dax1P 2.1kb plasmid and either pCAG-IP (control) or pCAGIP-Esrrb.  (C) Repression 
of the Dax1 gene promoter activity by knocking down of Esrrb.  A3-1 ES cells were transfected with pGL2-Dax1P 
546bp plasmid and either control vector (pFIV-H1/U6-puro) or Esrrb knockdown vector (pFIV-H1/U6-Esrrb#3-
puro).  Luciferase activity was measured 48h after transfection. The bars represent the means and standard 
deviation of three independent experiments. 
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FIG. 5.  Esrrb regulates promoter activity of the Dax1 gene via ERRE1.  (A) Schematic view of pGL4.10-Dax1 
promoter 546 bp (pGL4.10-Dax1P 546 bp) and putative Esrrb-binding sites (Dax1-ERRE1 and 2).  To determine 
Esrrb responsive elements of the Dax1 gene, four reporter plasmids including wild-type (WT), ERRE1 mutated 
(mutERRE1), ERRE2 mutated (mutERRE2), and ERRE1 and 2 mutated (mutERRE1&2) promoters were designed.  
The mutated sequence of ERRE was changed from AGGTCA to ATTTAA.  (B) ERRE1 is involved in promoter 
activity of the Dax1 gene.  A3-1 ES cells were transfected with either pGL4.10 (empty vector, ev), pGL4.10-Dax1P 
546 bp-WT, -mutERRE1, -mutERRE2 or -mutERRE1&2.  Luciferase activity was measured 48h after transfection.  
The bars represent the means and standard deviations of three independent experiments.  (C) Esrrb directly binds to 
Dax1-ERRE1 in vitro.  Nuclear extracts from A3-1 ES cells were subjected to pull-down assay with biotinylated 
DNA.  The biotin-labeled Dax1-ERRE1 oligonucleotide was incubated with nuclear extracts from A3-1 ES cells 
either with or without 50-fold non-labeled wild-type Dax1-ERRE1 or mutated Dax1-ERRE1 oligonucleotide.  The 
precipitates, as well as nuclear extracts were analyzed by Western blotting with anti-Esrrb antibody.  (D) Esrrb 
binds to Dax1-ERRE1 in vivo.  Chromatin immunoprecipitation (ChIP) assay was performed using normal IgG and 
anti-Esrrb antibody.  The precipitates were examined by PCR using specific primers; and PCR products were 
subjected to 1.5% agarose gel electrophoresis. All results are representative of three separate experiments.  
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FIG. 6.  Esrrb regulates expression of Dax1 in an Oct3/4-independent manner.  (A) Esrrb maintains expression of 
Dax1 in the absence of Oct3/4.  Control and Esrrb-overexpressing ZHBTc4 ES cells were cultured in the presence 
of LIF with (+) or without (-) 1μg/mL Tet for 24h - 48h.  Expression levels of Dax1, Esrrb and Oct3/4 were 
examined by RT-PCR.  (B) Knock-down of Esrrb leads to downregulation of Dax1 mRNA.  Either EGFP dsRNA 
(EGFP RNAi) or Esrrb dsRNAs (Esrrb RNAi #1 and #2) was introduced into A3-1 ES cells, and expression levels 
of Esrrb, Dax1 and Oct3/4 were analyzed 48h after transfection.  All samples were analyzed in triplicate and 
normalized with GAPDH expression.  (C) Knock-down of Esrrb leads to downregulation of Dax1 protein 
expression.  Either EGFP dsRNA (EGFP RNAi) or Esrrb dsRNAs (Esrrb RNAi #1) was introduced into A3-1 ES 
cells, and expression levels of Esrrb, Dax1 and Oct3/4 were analyzed 48h after transfection.  α-Tubulin was used as 
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FIG. 7.  Dax1 inhibits transcriptional activity of Esrrb.  (A) Transcriptional activity of Esrrb upon Dax1 expression 
is repressed by Dax1 in HEK293 cells.  Reporter plasmid carrying Esrrb-responsive element (ERRE) of the Dax1 
gene (pGL2-Dax1P 546 bp) was transfected into HEK293 cells with Flag-Dax1 and/or Myc-Esrrb. (B) 
Transcriptional activity of Esrrb upon Dax1 expression is repressed by Dax1 in A3-1 ES cells.  pGL2-Dax1P 546 
bp was transfected into A3-1 ES cells with Flag-Dax1 and/or Myc-Esrrb.  (C) Enhancer activity of the Esrrb-
ERRE2 was repressed by Dax1.  Reporter plasmid pGL4P-Esrrb-ERRE2 was transfected into A3-1 ES cells with or 
without Myc-Dax1.  (D) Enhancer activity of the Esrrb-ERRE4 was repressed by Dax1.   Reporter plasmid pGL4P-
Esrrb-ERRE4 was transfected into A3-1 ES cells with or without Myc-Dax1.  Luciferase activity was measured 48h 
after transfection.  The bars represent the means and standard deviations of three independent experiments. 
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Uranishi et al.  Fig.8 continued 
FIG. 8.  Oct3/4, Dax1 and Esrrb have a competitive inhibition capacity for their interaction.  (A) Oct3/4 is 
competed out from Dax1-Oct3/4 complex in the presence of excess amounts of Esrrb.  HEK293 cells were 
transfected with Myc-Oct3/4 and Flag-MBP-Dax1 with or without Myc-Esrrb (0 ng, 50 ng or 100 ng).  Flag-MBP-
Dax1 was pulled down by amylose resin, and precipitates were analyzed by Western blotting with either anti-
Oct3/4 or anti-Esrrb antibodies.  (B) Esrrb is competed out from Dax1-Esrrb complex in the presence of excess 
amounts of Oct3/4.  HEK293 cells were transfected with Myc-Esrrb and Flag-MBP-Dax1 with or without Myc-
Oct3/4 (0 ng, 100 ng or 600 ng).  Flag-MBP-Dax1 was pulled down by amylose resin, and precipitates were 
analyzed by Western blotting with either anti-Oct3/4 or anti-Esrrb antibodies.  Expression of each protein was 
confirmed by Western blotting with anti-Oct3/4, anti-Esrrb and anti-Flag antibodies, respectively.  (C) Oct3/4 does 
not associate with Dax1 LTm in the presence of excess amount of Esrrb.  HEK293 cells were transfected with 
Oct3/4 and Flag-MBP-Dax1 LTm with or without Esrrb (0 ng, 100 ng or 200 ng).  Flag-MBP-Dax1 LTm was 
pulled down by amylose resin, and precipitates were analyzed by Western blotting with either anti-Oct3/4 or anti-
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FIG. 9.  Inhibition of Dax1-Esrrb interaction causes up-regulation of endodermal marker genes.  (A) Control and 
Esrrb-overexpressing A3-1 ES cells were transfected with either EGFP dsRNA (EGFP RNAi) or Dax1 dsRNAs 
(Dax1 RNAi), and expression of the indicated genes was analyzed 96h after transfection. (B) Control and Esrrb-
overexpressing A3-1 ES cells were transfected with either pCAGIP-Myc or Myc-Dax1LTm, and expression of the 
indicated genes including endogenous Dax1 (Dax1(endo)) was analyzed 96h after transfection.  All samples were 
analyzed in triplicate and normalized with GAPDH expression.  A value that is significantly different from the 







Uranishi et al. Fig.10 
Fig. 10.  Proposed model of Dax1, Esrrb and Oct3/4 interaction.  Oct3/4 and Esrrb induce the expression of Dax1.  
Dax1 associates with Oct3/4 or Esrrb and represses transcriptional activity of them.  Oct3/4 and Esrrb interact and 
regulate gene expression of each other.  The proposed regulatory network contributes to control pluripotency and 
self-renewal capacity of ES cells. 
Supplemental Table 1.  Nucleotide sequences 
Oligonucleotide 
names 
  Sequences (5' to 3') 
For RT-PCR 
analysis   
GAPDH F TGATGACATCAAGAAGGTGGTGAAG 
 
R TCCTTGGAGGCCATGTAGGCCAT 
Oct3/4 F GCCCTGCAGAAGGAGCTAGAAC 
 
R GGAATACTCAATACTTGATCT 
Esrrb F TAGGGGTTGAGCAGGACAAG 
 
R CTACCAGGCGAGAGTGTTCC 
Dax1 F CAGATCCGCTGAACTGAACA 
 
R CTACGACCGCTTTCTCCATC 
Gata4 F GCCTGTATGTAATGCCTGCG 
 
R CCGAGCAGGAATTTGAAGAGG 
Gata6 F GCAATGCATGCGGTCTCTAC 
 
R CTCTTGGTAGCACCAGCTCA 
Dab2 F GGCAACAGGCTGAACCATTAGT 
 
R TTGGTGTCGATTTCAGAGTTTAGAT 
Fgf5 F GCTGTGTCTCAGGGGATTGT 
 
R CACTCTCGGCCTGTCTTTTC 













Dax1 full length F GAATTCATGGCGGGTGAGGACCACCCG 
 
R GCGGCCGCTCACAGCTTTGCACAGAGC 
Dax1 DBD F GAATTCATGGCGGGTGAGGACCACCCG 
 
R GCGGCCGCTACACCTGTGGATCCTTGAG 
Dax1 Q1a F GAATTCATGGCGGGTGAGGACCACCCG 
 
R GCGGCCGCTCATCGTGCCCTCGGCGCCTG 
Dax1 Q1b F GAATTCTTTTGTGGGGAGAATCAC 
 
R GCGGCCGCTATTCTCCGCAGAAACAACAGCG 
Dax1 Q23e F GAATTCGTGTGCGGTGAAGAGCAG 
 
R GCGGCCGCTAGCTGCGGTACAGGAAC 
Dax1 LBD F GAATTCGTGTGCGAGGCAGCGTCC 
 
R GCGGCCGCTCACAGCTTTGCACAGAGC 
Dax1 Q23 F GAATTCGGAGCACCTTGCTGGGGC 
 
R GCGGCCGCTACTCTTTGGTGTCAATGTTCAG 
Dax1 Q23-1 F GAATTCTGCGGAGAAGAGCAC 
 
R GCGGCCGCTACTCTTTGGTGTCAATGTTCAG 
Dax1 Q23-2 F GAATTCGGAGCACCTTGCTGGGGC 
 
R GCGGCCGCTAGAAGTGCAGGTGATCTTG 























Esrrb full length F GAATTCATGTCGTCCGAAGACAGGCAC 
 
R GCGGCCGCTCACACCTTGGCCTCCAGCATC 
Esrrb E1 F GAATTCATGTCGTCCGAAGACAGGCAC 
 
R GCGGCCGCTCACTTAGTCAATGGCTT 
Esrrb E2 F GAATTCATGTCGTCCGAAGACAGGCAC 
 
R GCGGCCGCTCACATCCCCACTTTGAG 
Esrrb E3 F GAATTCCTGAAGGAAGGTGTGCGC 
 
R GCGGCCGCTCACACCTTGGCCTCCAGCATC 
Esrrb E4 F GAATTCATCGTCTCGAATCTACTA 
 
R GCGGCCGCTCACACCTTGGCCTCCAGCATC 
Esrrb E5 F GAATTCTACATGCTTAACGCCATC 
 
R GCGGCCGCTCACACCTTGGCCTCCAGCATC 
Esrrb E7 F GAATTCTACATGCTTAACGCCATC 
 
R GCGGCCGCTCACTTAGTCAATGGCTT 
   
For reporter 



































































































   




















































   
For knockdown analysis 













Dax1 dsRNA F ACCUGCACUUCGAGAUGAUGGAGAUCC 
 
R AUCUCCAUCAUCUCGAAGUGCAGGUGA 
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S-Fig. 1.  Verification of PCR products.  cDNA samples of A3-1 ES cells were synthesized with (+) or without (-) 
reverse transcriptase (RT), and PCR analysis was performed using specific primers.  PCR products were subjected 

































































Supplemental Figure 2 
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S-FIG. 2.  Identification of an Oct3/4-responsive element of the Esrrb gene.  (A) Putative Oct3/4-binding sites of 
the Esrrb gene.  The intron regions contain two putative Oct3/4-binding sites, which we named Oct3/4 #A (+8924 - 
+8931) and Oct3/4 #B (+34733 - +34740).  Schematic view is not drawn to scale. (B) Oct3/4 #A is the Oct3/4-
responsive element of the Esrrb gene.  ZHBTc4 ES cells were transfected with either pGL4P-Oct3/4 #A or -Oct3/4 
#B.  The Oct3/4 #A site, but not #B site, was activated by Oct3/4.  (C) Mutation of the Oct3/4 #A site loses 
enhancer activity.  ZHBTc4 ES cells were transfected with either wild-type of pGL4P-Oct3/4 #A (WT) or mutated 
one (mut).  ZHBTc4 ES cells were divided into two dishes 24h after transfection and cultured with (+) or without (-
) 1μg/mL Tet for another 24 hours, and luciferase activity was measured.  Sequence of the Oct3/4-responsive 
element was changed from ATGCAAAT to GTGCCGCT.  The bars represent the means and standard deviations of 
three independent experiments.  
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Supplemental Figure 3 
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S-FIG. 3.  Oct3/4 binds to both 101 aa-135 aa and 309 aa-379 aa regions of Dax1.  (A) Schematic view of Flag-
MBP-Dax1 and its truncated mutants.  Several Flag-tagged MBP-fused constructs including full-length of Dax1 
(amino acids 1 - 472), Q23 (amino acids 101 - 379), Q23-1 (amino acids 136 - 379), Q23-2 (amino acids 101 - 308) 
and Q23a (amino acids 136 - 308) were designed.  (B) Determination of Oct3/4-interaction domains of Dax1.  
HEK293 cells were transfected with Myc-Oct3/4 together with Flag-MBP-Dax1 or its mutants.  MBP-fused 
proteins were pulled down by amylose resin, and precipitates were analyzed by Western blotting with anti-Myc 
antibody.  Expression of each protein was confirmed by Western blotting with anti-Myc and anti-Flag antibodies.  
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Supplemental Figure 4 
S-FIG. 4.  LXXLL motifs of Dax1 are crucial for the interaction with Esrrb but not with Oct3/4.  (A) Schematic 
view of Dax1 LTm.  Amino acid sequences of the three LXXLL motifs of Dax1 were changed from LXXLL to 
LXXAA, and the mutated form was named Dax1 LTm.  (B) Esrrb associates with wild-type Dax1 (Dax1 WT) but 
not Dax1 LTm.  HEK293 cells were transfected with Myc-Esrrb together with Flag-MBP-Dax1 WT or -Dax1 LTm.  
MBP-fused proteins were pulled down by amylose resin, and precipitates were analyzed by Western blotting with 
anti-Myc antibody.  Expression of each protein was confirmed by Western blot analysis with anti-Myc and anti-
Flag antibodies.  (C) Oct3/4 associates with Dax1 WT and Dax1 LTm.  HEK293 cells were transfected with Myc-
Oct3/4 together with Flag-MBP-Dax1 WT or -Dax1 LTm.  MBP-fused proteins were pulled down by amylose resin, 
and precipitates were analyzed by Western blotting with anti-Myc antibody.  Expression of each protein was 




































Supplemental Figure 5 
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S-FIG. 5.  Identification of Esrrb-responsive elements of the Esrrb gene.  (A) Putative Esrrb-binding sites of the 
Esrrb gene.  Intron regions of the Esrrb gene contain four putative Esrrb-binding sites, which we named Esrrb-
ERRE1 (+9711 - +9719), Esrrb-ERRE2 (+31943 - +31951), Esrrb-ERRE3 (+33435 - +33443) and Esrrb-ERRE4 
(+34403 - +34411). Schematic view is not drawn to scale.  (B) Esrrb-ERRE2 and Esrrb-ERRE4 have an enhancer 
activity in ES cells.  A3-1 ES cells were transfected with either pGL4-promoter (pGL4P, control), pGL4P-Esrrb-
ERRE1, -ERRE2, -ERRE3 or -ERRE4.  (C) Enhancer activity of ERRE2 of the Esrrb gene is repressed by 
knocking down of endogenous Esrrb expression in ES cells.  A3-1 ES cells were transfected with pGL4P-Esrrb-
ERRE2 together with or without Esrrb dsRNA (Esrrb RNAi #1).  (D) Enhancer activity of ERRE4 of the Esrrb 
gene is repressed by knocking down of endogenous Esrrb expression in ES cells.  A3-1 ES cells were transfected 
with pGL4P-Esrrb-ERRE4 together with or without Esrrb dsRNA (Esrrb RNAi #1).   (E) Enhancer activity of 
Esrrb-ERRE2 is diminished by introducing mutation into the elements.  A3-1 ES cells were transfected with either 
pGL4P (control), pGL4P-Esrrb-ERRE2 WT or -ERRE2 mutant.  (F) Enhancer activity of Esrrb-ERRE4 is 
diminished by introducing mutation into the elements.  A3-1 ES cells were transfected with either pGL4P (control), 
pGL4P-Esrrb-ERRE4 WT or -ERRE4 mutant.  Luciferase activity was measured 48h after transfection.  (G) Esrrb 
directly binds to both Esrrb-ERRE2 and Esrrb-ERRE4.  Nuclear extracts from A3-1 ES cells were subjected to 
pull-down assay with biotinylated DNA.  Biotin-labeled oligonucleotides (Esrrb-ERRE2 and Esrrb-ERRE4) were 
incubated with nuclear extracts from A3-1 ES cells either with or without 50-fold non-labeled wild-type or mutated 
oligonucleotide.  The precipitates, as well as nuclear extracts, were analyzed by Western blotting with anti-Esrrb 
antibody.  All results are representative of three separate experiments. 
